跳转至内容
Merck
CN

693030

Sigma-Aldrich

(S)-T-BINAP

别名:

(S)-(-)-2,2′-双(二对甲苯基膦)-1,1′-二联萘, (S)-Tol-BINAP

登录查看公司和协议定价

选择尺寸

2 G
¥1,429.29

¥1,429.29


预计发货时间2025年9月01日详情


获取大包装报价

选择尺寸

变更视图
2 G
¥1,429.29

About This Item

经验公式(希尔记法):
C48H40P2
CAS Number:
分子量:
678.78
MDL编号:
UNSPSC代码:
12352005
PubChem化学物质编号:
NACRES:
NA.22

¥1,429.29


预计发货时间2025年9月01日详情


获取大包装报价

表单

solid

质量水平

旋光性

[α]20/D -156°, c = 0.5 in benzene

mp

250-255 °C

官能团

phosphine

SMILES字符串

P(c8ccc(cc8)C)(c7ccc(cc7)C)c1c(c6c(cc1)cccc6)c2c3c(ccc2P(c5ccc(cc5)C)c4ccc(cc4)C)cccc3

InChI

1S/C48H40P2/c1-33-13-23-39(24-14-33)49(40-25-15-34(2)16-26-40)45-31-21-37-9-5-7-11-43(37)47(45)48-44-12-8-6-10-38(44)22-32-46(48)50(41-27-17-35(3)18-28-41)42-29-19-36(4)20-30-42/h5-32H,1-4H3

InChI key

IOPQYDKQISFMJI-UHFFFAOYSA-N

比较类似商品

查看完整比较结果

显示差异

1 of 4

此商品
615595490865490199
assay

99% (CP)

assay

-

assay

99% (CP)

assay

-

isotopic purity

99 atom % 13C

isotopic purity

98 atom % D

isotopic purity

99 atom % 13C

isotopic purity

99 atom % 13C

mass shift

M+2

mass shift

M+2

mass shift

M+2

mass shift

M+2

Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

200

form

solid

form

solid

form

solid

form

solid

mp

137-140 °C (lit.)

mp

137-140 °C (lit.)

mp

52-54 °C (lit.)

mp

132-135 °C (dec.) (lit.)

应用

( S )-T-BINAP 与硝酸银反应生成 ( S )-Tol-BINAP·AgNO 3 ,可催化醛的对映选择性烯丙基化反应生成对映体纯的仲醇。[1]可作为钯催化的碘芳烃不对称双碳氢化反应中的手性配体,形成 α-氨基酰胺类。[2]它还能催化 --丁基苯胺衍生物与碳酸二烯丙酯的不对称 N -烯丙基化反应,生成手性 N -烯丙基 --丁基苯胺。[3]

法律信息

与 Takasago 联合销售,仅供研究使用。

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)

法规信息

新产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Kamonpan Sanachai et al.
RSC medicinal chemistry, 12(3), 430-438 (2021-05-29)
The Janus kinase (JAK) and epidermal growth factor receptor (EGFR) have been considered as potential targets for cancer therapy due to their role in regulating proliferation and survival of cancer cells. In the present study, the aromatic alkyl-amino analogs of
Kamonpan Sanachai et al.
ACS omega, 7(37), 33548-33559 (2022-09-27)
Janus kinases (JAKs) are nonreceptor protein tyrosine kinases that play a role in a broad range of cell signaling. JAK2 and JAK3 have been involved in the pathogenesis of common lymphoid-derived diseases and leukemia cancer. Thus, inhibition of both JAK2
Kamonpan Sanachai et al.
ACS omega, 7(37), 33587-33598 (2022-09-27)
Janus kinases (JAKs) are involved in a wide variety of cell signaling associated with T-cell and B-cell mediated diseases. The pathogenesis of common lymphoid-derived diseases and leukemia cancer has been implicated in JAK2 and JAK3. Therefore, to decrease the risk
Kamonpan Sanachai et al.
ACS omega, 5(1), 369-377 (2020-01-21)
Janus kinases (JAKs) are enzymes involved in signaling pathways that affect hematopoiesis and immune cell functions. JAK1, JAK2, and JAK3 play different roles in numerous diseases of the immune system and have also been considered as potential targets for cancer
Chalita Washington et al.
PLoS genetics, 16(6), e1008715-e1008715 (2020-06-20)
Dysregulation of the Ras oncogene in development causes developmental disorders, "Rasopathies," whereas mutational activation or amplification of Ras in differentiated tissues causes cancer. Rabex-5 (also called RabGEF1) inhibits Ras by promoting Ras mono- and di-ubiquitination. We report here that Rabex-5-mediated

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持